Evidence map›Paper›PMID 32943491›Full record

ArticleJournal of the American Society of Nephrology : JASN2020

The Mechanism of Kidney Disease Due to APOL1 Risk Variants.

Etienne Pays

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Update on APOL1 and chronic kidney diseases in children.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  2. Article
  3. Kidney medicine · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Etienne PaysLaboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, Gosselies, Belgium epays@ulb.ac.be.
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic VariationActomyosinApolipoprotein L1Golgi ApparatusHumansKidney DiseasesMinor Histocompatibility AntigensMitochondrial DynamicsPhenotypePhosphatidylinositol PhosphatesPhosphotransferases (Alcohol Group Acceptor)PodocytesActomyosinAPOL1 protein, humanApolipoprotein L1Minor Histocompatibility Antigensphosphatidylinositol 4-phosphatephosphatidylinositol phosphate 4-kinasePhosphatidylinositol PhosphatesPhosphotransferases (Alcohol Group Acceptor)APOL1 risk variantsAPOL3chronic glomerulonephritischronic kidney diseasecytoskeletonend stage kidney diseasefocal segmental glomerulosclerosisGolgi PI(4)PPI4KB

Identifiers

PMID32943491
PMCPMC7608952
OpenAlexW3087093710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.